Medtronic cuts accused doctor loose

U.S. Sen. Charles Grassley expressed concern that a list of consultants provided to him by Medtronic doesn't include a doctor accused of falsifying data in a favorable study of the company's Infuse bone-graft product. Meanwhile, the device maker said Wednesday it had suspended its consulting agreement with the former military doctor accused by the Army of faking that research. Report | Report

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Incyte and Novartis' Jakafi is eying a nod in chronic graft vs. host disease—and it may just have the data to get it done.

With a slate of vaccine authorizations on the horizon, vaccine execs from a trio of leading shot makers are looking at distribution hurdles ahead.

News of an FDA plant inspection for a Macrogenics drug boosted investor confidence in BMS' ability to meet its year-end deadline for liso-cel.